Stephanie Okey Crinetics Pharmaceuticals, Inc. (CRNX) insider trading activity

CRNX Quotes by TradingView

Stephanie Okey is of Crinetics Pharmaceuticals, Inc.. Currently has a direct ownership of 16,300 shares of CRNX, which is worth approximately $491,608. The most recent transaction as insider was on Jun 11, 2025, when has been sold 6,900 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.3K
73.4% 3M change
73.4% 12M change
Total Value Held $491,608

Stephanie Okey Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 11 2025
BUY
Grant, award, or other acquisition
-
6,900 Added 29.74%
16,300 Common Stock
Jun 07 2024
BUY
Grant, award, or other acquisition
-
3,400 Added 26.56%
9,400 Common Stock
Mar 28 2024
SELL
Open market or private sale
$811,650 $46.38 p/Share
17,500 Reduced 74.47%
6,000 Common Stock
Mar 28 2024
BUY
Exercise of conversion of derivative security
$320,075 $18.29 p/Share
17,500 Added 42.68%
23,500 Common Stock
Jun 16 2023
BUY
Grant, award, or other acquisition
-
6,000 Added 50.0%
6,000 Common Stock

Also insider at

PTCT
PTC THERAPEUTICS, INC. Healthcare
ALBO
ALBIREO PHARMA, INC. Healthcare
Director
CTLT
Catalent, Inc. Healthcare
SO

Stephanie Okey

San Diego, CA

Track Institutional and Insider Activities on CRNX

Follow Crinetics Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRNX shares.

Notify only if

Insider Trading

Get notified when an Crinetics Pharmaceuticals, Inc. insider buys or sells CRNX shares.

Notify only if

News

Receive news related to Crinetics Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRNX